Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Ken Takezawa"'
Autor:
William Pao, Katerina Politi, Marc Ladanyi, Vincent A. Miller, Mark G. Kris, Greg J. Riely, Mary Ann Melnick, Paula J. Spitzler, Yelena Y. Janjigian, Kadoaki Ohashi, Elisa de Stanchina, Xiaoling Song, Caroline A. Nebhan, Maria E. Arcila, Valentina Pirazzoli, Ken Takezawa
PDF file - 29K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e81303a947277cc98b2ab20a60bda7d6
https://doi.org/10.1158/2159-8290.22528488
https://doi.org/10.1158/2159-8290.22528488
Autor:
William Pao, Katerina Politi, Marc Ladanyi, Vincent A. Miller, Mark G. Kris, Greg J. Riely, Mary Ann Melnick, Paula J. Spitzler, Yelena Y. Janjigian, Kadoaki Ohashi, Elisa de Stanchina, Xiaoling Song, Caroline A. Nebhan, Maria E. Arcila, Valentina Pirazzoli, Ken Takezawa
PDF file - 92K, Effects of HER2 overexpression on the sensitivity of HCC827 cells to EGFR TKIs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05ea9dddca376f4a0b91c8c4704bbfd8
https://doi.org/10.1158/2159-8290.22528491
https://doi.org/10.1158/2159-8290.22528491
Autor:
William Pao, Katerina Politi, Marc Ladanyi, Vincent A. Miller, Mark G. Kris, Greg J. Riely, Mary Ann Melnick, Paula J. Spitzler, Yelena Y. Janjigian, Kadoaki Ohashi, Elisa de Stanchina, Xiaoling Song, Caroline A. Nebhan, Maria E. Arcila, Valentina Pirazzoli, Ken Takezawa
PDF file - 91K, Levels of HER2 affect the sensitivity of EGFR-mutant NSCLC cells to EGFR TKIs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dadeef263aa2d399613456739e442c7
https://doi.org/10.1158/2159-8290.22528494.v1
https://doi.org/10.1158/2159-8290.22528494.v1
Autor:
William Pao, Katerina Politi, Marc Ladanyi, Vincent A. Miller, Mark G. Kris, Greg J. Riely, Mary Ann Melnick, Paula J. Spitzler, Yelena Y. Janjigian, Kadoaki Ohashi, Elisa de Stanchina, Xiaoling Song, Caroline A. Nebhan, Maria E. Arcila, Valentina Pirazzoli, Ken Takezawa
PDF file - 36K, Increased murine Her2 expression in erlotinib-resistant mutant EGFR-induced transgenic mouse tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a752b47a07457a9f27af28370550837
https://doi.org/10.1158/2159-8290.22528497.v1
https://doi.org/10.1158/2159-8290.22528497.v1
Autor:
Kazuhiko Nakagawa, Kazuto Nishio, Erina Hatashita, Haruka Yamaguchi, Kiyoko Kuwata, Ken Takezawa, Hiroyasu Kaneda, Hidetoshi Hayashi, Kaoru Tanaka, Kazuko Sakai, Takafumi Okabe, Isamu Okamoto, Junko Tanizaki
PDF file, 80K, Level of EML4-ALK mRNA in NSCLC cells. Total RNA extracted from the indicated cell lines was subjected to RT and real-time PCR analysis for determination of the abundance of EML4-ALK mRNA. Data were normalized by the amount of GAPDH mR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a8e36b5ba0c82c7a5234de7bd2bee8f
https://doi.org/10.1158/1078-0432.22446444.v1
https://doi.org/10.1158/1078-0432.22446444.v1
Autor:
Kazuhiko Nakagawa, Kazuto Nishio, Erina Hatashita, Haruka Yamaguchi, Kiyoko Kuwata, Ken Takezawa, Hiroyasu Kaneda, Hidetoshi Hayashi, Kaoru Tanaka, Kazuko Sakai, Takafumi Okabe, Isamu Okamoto, Junko Tanizaki
PDF file, 65K.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14f05eed2f1c81a2e6b94271f968b916
https://doi.org/10.1158/1078-0432.22446441
https://doi.org/10.1158/1078-0432.22446441
Autor:
Kazuhiko Nakagawa, Kazuto Nishio, Masahiro Fukuoka, Haruka Yamaguchi, Kiyoko Kuwata, Junko Tanizaki, Isamu Okamoto, Ken Takezawa
Supplementary Data from Enhanced Anticancer Effect of the Combination of BIBW2992 and Thymidylate Synthase–Targeted Agents in Non–Small Cell Lung Cancer with the T790M Mutation of Epidermal Growth Factor Receptor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1becf47be73166a164e81c4a2e7978e9
https://doi.org/10.1158/1535-7163.22485189
https://doi.org/10.1158/1535-7163.22485189
Autor:
Kazuhiko Nakagawa, Kazuto Nishio, Masahiro Fukuoka, Kazuyoshi Yanagihara, Tokuzo Arao, Kiyoko Kuwata, Yuki Yamada, Erina Hatashita, Ken Takezawa, Kunio Okamoto, Takeshi Yoshida, Isamu Okamoto, Wataru Okamoto
Therapeutic strategies that target c-Src hold promise for a wide variety of cancers. We have now investigated both the effects of dasatinib, which inhibits the activity of c-Src and several other kinases, on cell growth as well as the mechanism of da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ca4d3c142725765400486b145fa2272
https://doi.org/10.1158/1535-7163.c.6532190
https://doi.org/10.1158/1535-7163.c.6532190
Supplementary Figure S1.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c6d1845e3044c22928ac4eea45761ae
https://doi.org/10.1158/1078-0432.22442207
https://doi.org/10.1158/1078-0432.22442207
Autor:
Kazuhiko Nakagawa, Kazuto Nishio, Erina Hatashita, Haruka Yamaguchi, Kiyoko Kuwata, Ken Takezawa, Hiroyasu Kaneda, Hidetoshi Hayashi, Kaoru Tanaka, Kazuko Sakai, Takafumi Okabe, Isamu Okamoto, Junko Tanizaki
Purpose: Anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors (TKI) such as crizotinib show marked efficacy in patients with non–small cell lung cancer positive for the echinoderm microtubule-associated protein–like 4 (EML4)–ALK fusion p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7763d82998d6510b3996807b4971ed78
https://doi.org/10.1158/1078-0432.c.6520755
https://doi.org/10.1158/1078-0432.c.6520755